Lb Pharmaceuticals INC (LBRX) SEC Filings — 2025
6 SEC filings for Lb Pharmaceuticals INC (LBRX) in 2025.
Filings
- LB Pharmaceuticals Enters Material Definitive Agreement — 8-K · Nov 13, 2025
- LB Pharmaceuticals Files 8-K — 8-K · Nov 12, 2025
- LB Pharma Slashes Losses, Boosts Cash by 10x in Q3 — 10-Q · Nov 6, 2025
- LB Pharmaceuticals Files 8-K with Bylaw Amendments — 8-K · Sep 12, 2025
- LB Pharma's Schizophrenia Drug Nears Phase 3, Targets $12B Market — S-1/A · Sep 8, 2025
- LB Pharmaceuticals Eyes Nasdaq Debut with Phase 3-Ready Schizophrenia Drug — S-1 · Aug 22, 2025